维普中文期刊产品整合服务
21篇 您的检索式:作者名="Lv BY"
    题名 作者 年代 出处 被引量
1P-chlorophenol wastewater treatment by microwave-enhanced catalytic wet peroxide oxidation 显示文摘Zhao GH Lv BY Jin Y 2010Water Environment Research2010,82,2:1
2Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in nonsmall cell lung cancer patients treated with gefitinib or erlotinib显示文摘Jackman DM Yeap BY Sequist LV 0,,13:1
3Immune response spike protein from transmissible gastroenteritis coronavirus expressed in mouse mammary cell显示文摘Peng S Y Lv induced by N Zhang Y 2007Virus Res2007,128,12:1
4Fluorescent quantitative PCR ofMycobacterium tuberculosis for differentiating intestinaltuberculosis from Crohn、disease显示文摘Fei BY Lv HX Zheng WH 2014Braz J Med Biol Res2014,47,2:1
5Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib显示文摘Jackman DM Yeap BY Sequist LV 2006Clin Cancer Res2006,12,13:1
6Exon 19 deletion mutations of epidermal grnwth treated with gefitinib or erlotinib显示文摘Jackman DM Ycep BY Scquist LV 2006Clin Cancer Res2006,12,13:1
7Nanoparticles functional-ized with Pep-1 as potential glioma targeting delivery system viainterleukin 13 receptor a2-mediated endocytosis 显示文摘WANG BY LV LY’WANG ZY et at 2014Biomateri-als2014,35,22:1
8Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolinged survival in non-small cell lung cancer patients treated with gefitinb or erlotinib显示文摘Jackaman DM Yeap BY Sequist LV 2006Clin Cancer Res2006,12,13:1
9Exon 19 dele-tion mutations of epidermal growth factor receptor are as-sociated with prolonged survival in non-small cell lungcancer patients treated with gefitinib or erlotinib显示文摘Jackman DM Yeap BY Sequist LV 2006ClinCancer Res2006,12,13:1
10Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib 显示文摘Jackman DM Yeap BY Sequist LV 2006Clin Cancer Res2006,12,13:1
11Exon 19deletionmutations of epidermal growth factor receptor are associatedwith prolonged survival in non-small cell lung cancer patientstreated with gefitinib or erlotinib显示文摘Jackman DM Yeap BY Sequist LV 2006Clin Cancer Res2006,12,13:1
12Yantai muping a gold surface collapse characteristics and prevention countermeasures study 显示文摘meng long by the king Lv Baoping Zhao Fei 2015Journal of green science and technology2015,,04:1
13Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population显示文摘Fei BY Lv HX Yang JM 2008Cytokine2008,41,1:1
14Exon 19 deletion mu- tations of epidermal growth factor receptor are associated with pro- longed survival in non-small cell lung cancer patients treated with gefitinib or erlotinib显示文摘Jaekman DM Yeap BY Sequist LV 2006Clin Cancer Res2006,12,13:1
15Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptorα2-mediated endocytosis显示文摘Wang BY Lv LY Wang ZY 2014Biomaterials2014,35,22:1
16P-chlorophenol wastewater treatment by microwave-enhanced catalytic wet peroxide oxidation 显示文摘Zhao GH Lv BY Jin Y 2010Water Environment Research2010,82,2:1
17Exon 19 deletion mutations of epidermal growth treated with gefitinib or erlotinib显示文摘Jackman DM Yeap BY Sequist LV 2006Clin Cancer Res2006,12,13:1
18Exon 19 deletion muta-tions of epidermal growth treated with gefitinib or erlotinib显示文摘Jackman DM Yeap BY Sequist LV 2006ClinCancer Res2006,12,13:1
19Ante-partum and post-partum mark?ers of metabolic syndrome in pre-eclampsia显示文摘Lei Q Lv W Zhang BY 2011J Hum Hypertens2011,25,1:1
20Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with Gefitinib or Erlotinib显示文摘Jackman DM Yeap BY Sequist LV 2006Clin Cancer Res2006,12,13:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费